More importantly, we identified that NAR might interfere with a mitochondrial diversion in CD4+ T cells and thus regulate their polarization and migration properties, which corroborates its potential as an alternative therapeutic option for RA. The gene discussed is CPSF4; the disease is rheumatoid arthritis.